<p>The present invention is directed to modulating an immune response in an animal comprising administering a vaccine or pharmaceutical composition comprising an immunogen and an adjuvant which comprises a polynucleotide comprising one or more regions of nucleic acid operably encoding a CXCL11 polypeptide or fragment, variant, or derivative thereof. The present invention is further directed to modulating an immune response in an animal comprising administering a vaccine or pharmaceutical composition comprising an immunogen and an adjuvant which comprises a CXCL11 polypeptide or fragment, variant, or derivative thereof. The immune response elicited by administration of the composition of the present invention is improved relative to administration of the immunogen in the absence of the adjuvant:</p>
申请公布号
WO2009014382(A2)
申请公布日期
2009.01.29
申请号
WO2008KR04317
申请日期
2008.07.23
申请人
POSTECH ACADEMY-INDUSTRY FOUNDATION;GENEXINE CO., LTD.;SUNG, YOUNG CHUL;YANG, SEHWAN;NAMKOONG, HONG;XUAN, BUI THANH;IM, SE JIN
发明人
SUNG, YOUNG CHUL;YANG, SEHWAN;NAMKOONG, HONG;XUAN, BUI THANH;IM, SE JIN